Primary Recipient

GLOBAL VACCINES INC

Amount

$414,971.00

Award Date

7/15/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Although the use of highly active anti-retroviral therapy (HAART) has enhanced both the longevity and quality of life for HIV-infected individuals by controlling viral replication, financial and logistic drawbacks as well as clinical side effects and the

Recipients Connected to Award

Recipient	Role	Amount
GLOBAL VACCINES INC	Primary recipient	$401,210.00
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL	Sub-recipient	$13,761.00

Vendors Connected to Award

Vendor	Role	Amount
AccuTek Laboratories	Primary vendor	$0.00
EMD Chemicals, Inc.	Primary vendor	$99.13
EBIOSCIENCE, INC	Primary vendor	$250.00
FISHER SCIENTIFIC COMPANY L.L.C.	Primary vendor	$6,437.72
Invitrogen	Primary vendor	$463.28
Regency Cleaners	Primary vendor	$60.03
VWR International	Primary vendor	$623.84
Bio-Rad Laboratories	Primary vendor	$582.59
Praxair Distribution Inc.	Primary vendor	$147.55
Carolina Vaccine Institute	Primary vendor	$2,877.42
Brisky Pet Products	Primary vendor	$75.38
Kelly Young	Primary vendor	$50.68
BD Biosciences	Primary vendor	$357.62
ZeptoMetrix	Primary vendor	$2,722.83